Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • alzbeta_h
    Junior Member
    • Mar 2019
    • 1

    #1

    Mutect2 tumor-only - missing CHROM, ID, QUAL and FILTER columns in output vcf

    Hi,

    I am a medical student new to NGS. I'm currently trying to count the tumor mutational load from tumor samples (FFPE) to which I have no matched normal tissue. We are using a gene panel of less than 70 genes.

    I have got the fastq files (2 files per sample, paired-end) and I tried to write a script in bash to generate recalibrated bam files ready for use with mutect2.

    However, when I received the output vcf file from mutect2, there are some mutations but there is no information in CHROM, ID, FILTER and QUAL column.
    I am attaching the commands I used. I suppose there might be a problem with alignment, but I failed to recognize where the problem is. As a complete beginner, I suppose maybe I do some kind of systemic error.
    I would be grateful for any kind of hint. THanks.


    Code:
    bwa index -a bwtsw hs37d5.fa | samtools faidx hs37d5.fa | picard CreateSequenceDictionary R=hs37d5.fa O=hs37d5.dict
    
    bwa mem -M  ~/projects/patologie/hs37d5/hs37d5.fa  ~/projects/patologie/01_raw_data/BRCA1_S1_L001_R1_001.fastq ~/projects/patologie/01_raw_data/BRCA1_S1_L001_R2_001.fastq > sample.sam 
    
    samtools view -bS sample.sam > sample.bam
    
    picard SortSam I=sample.bam O=sorted_sample.bam SORT_ORDER=coordinate
    
    picard MarkDuplicates I=sorted_sample.bam O=sample_marked.bam M=marked_metrics.txt ASSUME_SORT_ORDER=coordinate
    
    picard AddOrReplaceReadGroups I=sample_marked.bam  O=sample_rg.bam RGID=1 RGLB=lib1 RGPL=illumina RGPU=unit1 RGSM=1
    
    gatk IndexFeatureFile -F= ~/projects/patologie/reference/1000G_phase1.indels.b37.vcf 
    
    gatk IndexFeatureFile -F= ~/projects/patologie/reference/Mills_and_1000G_gold_standard.indels.b37.vcf 
    
    gatk IndexFeatureFile -F= ~/projects/patologie/reference/dbsnp_138.b37.vcf
    
    gatk BaseRecalibrator -R ~/projects/patologie/hs37d5/hs37d5.fa  -I sample_rg.bam --known-sites ~/projects/patologie/reference/1000G_phase1.indels.b37.vcf --known-sites ~/projects/patologie/reference/dbsnp_138.b37.vcf --known-sites ~/projects/patologie/reference/Mills_and_1000G_gold_standard.indels.b37.vcf -O recal_table
    
    gatk ApplyBQSR -bqsr recal_table -I sample_rg.bam -R ~/projects/patologie/hs37d5/hs37d5.fa -O sample_recal.bam
    
    gatk IndexFeatureFile -F= ~/projects/patologie/reference/af-only-gnomad.raw.sites.b37.vcf
    
    gatk Mutect2 -R ~/projects/patologie/hs37d5/hs37d5.fa -I ~/projects/patologie/analysis2/sample_recal.bam -tumor 1 -O sample_single.vcf --germline-resource ~/projects/patologie/reference/af-only-gnomad.raw.sites.b37.vcf

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...